TASE:INCRHI-TECH - BIOMED - CANNABIS
CULTIVATION & SUPPLY OF MEDICAL CANNABIS & INVESTS IN BIOMED COMPANIES.
44.82 MILS
388.68 MILS
27.37 M
About INTERCURE
Sector
Industry
CEO
Alexander Rabinovitch
Website
Headquarters
Herzliya
Founded
1994
ISIN
IL0011063760
FIGI
BBG000RN0197
InterCure Ltd. engages in the business of medical cannabis and biomedicine. It operates through the Investments in Biomed Portfolio Companies and Investments in Medical Cannabis Companies segments. The company was founded by Benjamin Gavish and Erez Gavish on November 20, 1994 and is headquartered in Herzliya, Israel.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of INCR is 930.0 ILA — it has increased by 2.42% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange INTERCURE stocks are traded under the ticker INCR.
INCR stock is 6.47% volatile and has beta coefficient of 1.39. Check out the list of the most volatile stocks — is INTERCURE there?
Yes, you can track INTERCURE financials in yearly and quarterly reports right on TradingView.
INCR stock has fallen by 1.22% compared to the previous week, the month change is a 25.12% rise, over the last year INTERCURE has showed a 18.34% increase.
Today INTERCURE has the market capitalization of 423.83 M, it has decreased by 0.50% over the last week.
No, INCR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, INCR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INTERCURE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INTERCURE technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INTERCURE stock shows the neutral signal. See more of INTERCURE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.